Drugs News and Research

RSS

Cancer-fighting antibodies may trigger autoimmune brain disorders

Consider two seemingly unrelated medical puzzles. First: Every day, our bodies produce hundreds of billions of new cells, many of which are mutated.

25 Mar 2026

Early blood test could guide personalized lymphoma treatment decisions

Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of treatment: an antibody designed to wipe out cancerous B cells plus a combination of four chemotherapy drugs.

25 Mar 2026

Blood pressure drug boosts effectiveness of cancer therapy

In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP, investigators found that the FDA-approved blood pressure drug telmisartan can significantly enhance the cancer-killing activity of the targeted therapy olaparib, potentially expanding its use to many more patients.

25 Mar 2026

COVID-19 virus evolved quickly but within strict genetic limits

A new paper in Genome Biology and Evolution, published by Oxford University Press, indicates that while the COVID-19 virus has developed rapidly since 2019, it has done so within limited genetic channels.

25 Mar 2026

Placental abruption linked to higher heart risk in children

The risk of developing early cardiovascular disease or dying from cardiovascular disease by the age of 28 was about 4.6 times higher among people born to mothers who had a placental abruption during their pregnancy.

25 Mar 2026

New pathway enhances brown fat thermogenesis and metabolic health

Researchers have determined how a key protein activates brown fat by expanding blood vessels and nerves in the heat-generating tissue.

25 Mar 2026

iXCells Biotechnologies joins international collaboration to evaluate chemotherapeutic toxicity in human organoids

iXCells Biotechnologies ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, today announced it has entered an international collaboration with Rosebud Biosciences ("Rosebud"), Kantify, and Incite to evaluate off-target chemotherapeutic toxicities in patient-specific organoids.

From iXCells Biotechnologies 25 Mar 2026

New nanoparticle system boosts scalable production of therapeutic exosomes

Researchers from Xi'an Jiaotong-Liverpool University (XJTLU) in China have developed a streamlined process that makes it easier to produce tiny therapeutic particles released by cells, called exosomes, which are being explored as a new type of medical treatment.

24 Mar 2026

Algorithm-guided insulin dosing improves blood sugar control in type 2 diabetes

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose adjustments, a new study found.

24 Mar 2026

Insilico and ASKA partner to advance AI-driven gynecological drug discovery

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced a strategic research collaboration with ASKA Pharmaceutical Co., Ltd. ("ASKA"), a specialized pharmaceutical company with a strong focus on internal medicine, obstetrics, and gynecology.

24 Mar 2026

Medicare reforms improve medication adherence among older adults with heart disease

Medicare beneficiaries with heart disease or major cardiovascular risk factors reported less cost-related medication non-adherence-skipping or reducing doses, delaying prescription fills or foregoing medications due to cost-after new provisions went into effect limiting out-of-pocket drug costs for Medicare beneficiaries, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.26) and simultaneously published in JACC, the flagship journal of the ACC.

24 Mar 2026

Drug-releasing stitches aim to reduce inflammation and improve healing

Deep cuts from accidents or surgeries require stitches, typically followed by oral anti-inflammatory medications like ibuprofen. While these medications help with pain, they don't act specifically on the wounds.

24 Mar 2026

Research reveals potential new strategy for targeting deadly small cell neuroendocrine cancers

UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for targeting tumors that have long resisted treatment.

23 Mar 2026

Scientists turn red blood cells into long-lasting drug and imaging carriers in mice

A new preclinical study shows that red blood cells can be tagged in vivo and used as long-lasting carriers for imaging agents and therapies, opening a new route for safer drug delivery and vascular imaging.

23 Mar 2026

Multiple sclerosis prevalence in England doubles due to better diagnosis

Multiple sclerosis (MS) has more than doubled in recorded prevalence in England from 2000 to 2020, increasing by 6% per year, largely due to improved diagnosis and longer life expectancy, finds a new study by University College London (UCL) and Imperial College London researchers.

23 Mar 2026

Fluorescent imaging enables real-time observation of Toxoplasma gondii's growth

It infects nearly one-third of the global population, yet its microscopic size makes the Toxoplasma gondii parasite difficult for scientists to study.

23 Mar 2026

Rising health costs push some middle-aged adults to skip the doc until Medicare

John Galvin knows he needs a colonoscopy. But he's waiting to schedule the procedure until December, when he turns 65 and qualifies for Medicare.

23 Mar 2026

Major UK clinical trial finds surfactant therapy ineffective for severe bronchiolitis

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for infants on life support with severe bronchiolitis - a seasonal viral illness that hospitalizes thousands of babies each year.

23 Mar 2026

Scientists identify new target to slow Huntington’s disease progression

Huntington's disease is a devastating brain disorder that slowly robs people of movement, memory and personality.

23 Mar 2026

Researchers explore "block and lock" strategy for functional HIV cure

For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs-commonly referred to as antiretroviral therapy-the virus usually rushes back within weeks.

23 Mar 2026